1. Home
  2. KZIA vs BON Comparison

KZIA vs BON Comparison

Compare KZIA & BON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • BON
  • Stock Information
  • Founded
  • KZIA 1994
  • BON 2006
  • Country
  • KZIA Australia
  • BON China
  • Employees
  • KZIA N/A
  • BON N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • BON Medicinal Chemicals and Botanical Products
  • Sector
  • KZIA Health Care
  • BON Health Care
  • Exchange
  • KZIA Nasdaq
  • BON Nasdaq
  • Market Cap
  • KZIA 7.8M
  • BON 6.6M
  • IPO Year
  • KZIA 1999
  • BON 2021
  • Fundamental
  • Price
  • KZIA $1.50
  • BON $1.32
  • Analyst Decision
  • KZIA Strong Buy
  • BON
  • Analyst Count
  • KZIA 1
  • BON 0
  • Target Price
  • KZIA $20.00
  • BON N/A
  • AVG Volume (30 Days)
  • KZIA 5.4M
  • BON 35.1K
  • Earning Date
  • KZIA 03-26-2025
  • BON 02-14-2025
  • Dividend Yield
  • KZIA N/A
  • BON N/A
  • EPS Growth
  • KZIA N/A
  • BON N/A
  • EPS
  • KZIA N/A
  • BON 0.17
  • Revenue
  • KZIA $1,655,324.00
  • BON $23,844,556.00
  • Revenue This Year
  • KZIA $806.89
  • BON $223.38
  • Revenue Next Year
  • KZIA N/A
  • BON $18.82
  • P/E Ratio
  • KZIA N/A
  • BON $7.32
  • Revenue Growth
  • KZIA 248000.00
  • BON N/A
  • 52 Week Low
  • KZIA $1.31
  • BON $1.11
  • 52 Week High
  • KZIA $15.80
  • BON $5.99
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 39.50
  • BON 42.13
  • Support Level
  • KZIA $1.31
  • BON $1.11
  • Resistance Level
  • KZIA $2.64
  • BON $1.30
  • Average True Range (ATR)
  • KZIA 0.24
  • BON 0.14
  • MACD
  • KZIA 0.09
  • BON -0.01
  • Stochastic Oscillator
  • KZIA 14.29
  • BON 36.20

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About BON Bon Natural Life Limited

Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from perfumes and fragrance products.

Share on Social Networks: